ArticlebioRxiv : the preprint server for biology2026
An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.
Sejal Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.